This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ecancer
J

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel in De Novo Metastatic PDAC"

By ecancer FEATURING Jennifer Knox
By ecancer FEATURING Jennifer Knox
0 views
June 20, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

2024 ASCO® Annual Meeting Insights Hub: GI Videos

12:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreat…

Feat. J. Knox
12:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

Feat. C. Eng
11:57
COR2ED The Heart of Medical Education

ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Ca…

Feat. M. Socinski, P. R. Galle, S. Dawood, E. Smyth, S. Klempner
View All

Recommended

AUTOPLAY
09:01
Integrity CE

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Feat. L. Zheng
12:50
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-…

Feat. E. Dotan
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
08:34
Yale Cancer Center

NORPACT-1 Trial Updates: Neoadjuvant FOLFIRINOX vs. Upfront Surgery …

Feat. J. Lacy
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron
31:40
Horizon CME

Updates in Perioperative Therapy of Pancreatic Cancer

Feat. P. Philip
07:42
Integrity CE

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Feat. W. Burns
03:50
UCLA Health

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

Feat. Z. Wainberg
12:08
Yale Cancer Center

GI Oncology Year in Review: Precision Medicine Update in Metastatic …

Feat. J. Lacy
07:37
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pem…

Feat. B. Weinberg
08:08
Integrity CE

Updates in Nonmetastatic Upper-GI Adenocarcinoma

Feat. J. Hernandez
10:53
Yale Cancer Center

GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …

Feat. J. Lacy
07:53
Total Health

Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia

Feat. D. Lin
39:04
2023 Johns Hopkins Updates in Gastrointestinal Cancers

Localized Pancreatic Cancer Controversial Cases: Panel Discussion

Feat. M. Katz, A. De Jesus-Acosta, N. Zaidi, J. He, A. Narang, T. Bekaii-Saab
25:56
OncoAlert

Year in Review: Pancreatic Cancers

Feat. M. Lewis
06:28
Shubham Pant

FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…

30:55
2023 Johns Hopkins Updates in Gastrointestinal Cancers

Medical Oncology Updates in Pancreas Cancer

Feat. T. Bekaii-Saab
22:10
Yale Cancer Center

Pancreatic Cancer Updates From Yale Cancer Center

Feat. J. Lacy
12:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreat…

Feat. J. Knox